Japan’s Ohara increases stakes in Fidson Healthcare


Nigerian pharmaceutical company, Fidson Healthcare Plc said it has sold more equity stakes in the company to Ohara Pharmaceutical Co. Ltd.

Ohara is a Japanese healthcare company.

The stake sale was done through a rights issue which saw Fidson selling more stakes to Ohara. The Japanese company now holds to 21.57% in Fidson.

Fidson said in a statement that the strategic alliance is aimed at supporting the company in fulfilling its commitment to provide the Nigerian market with the latest healthcare products and services.

“Given this growing population, there is no doubt that Nigeria is in urgent need of a rapid improvement in the standard of healthcare delivery. This can only be accelerated through modernization and technological intervention which the alliance with Ohara aims to deliver,” the company said.

The company shares are one of the lowest amongst its peers remaining at N4 per share in the last year